The Prosid study: Evaluating efficacy and safety of intravenous immunoglobulin (IVIG) 10% in primary infection prophylaxis in patients with chronic lymphocytic leukemia-study design Meeting Abstract


Authors: Cornely, O.; Mato, A.; Robak, T.; Mellinghoff, S.; Lavrova, T.
Abstract Title: The Prosid study: Evaluating efficacy and safety of intravenous immunoglobulin (IVIG) 10% in primary infection prophylaxis in patients with chronic lymphocytic leukemia-study design
Meeting Title: 62nd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 136
Issue: Suppl. 1
Meeting Dates: 2020 Dec 5-8
Meeting Location: Virtual
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2020-11-05
Language: English
ACCESSION: WOS:000607547201142
DOI: 10.1182/blood-2020-136898
PROVIDER: wos
Notes: Meeting Abstract: 20 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato